AVO.Lライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (31 8月 2023 @ 00:23):

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer...

Stats
本日の出来高	0.00
平均出来高	0.00
時価総額	10.44M
EPS	£0 ( 2024-03-01 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-0.270
ATR14	£0.371 (1 927.27%)

ボリューム相関

長: 0.04 (neutral)

短: 0.00 (neutral)

Signal:(10.771) Neutral

Advanced Oncotherapy PLC 相関

10 最も正の相関
TRLS.L	0.973
TBLD.L	0.969
GAL.L	0.966
KIST.L	0.964
IDHC.L	0.961
CNS.L	0.961
SEEN.L	0.96
MAC.L	0.959
WATR.L	0.958
3SFB.L	0.958

10 最も負の相関
WAND.L	-0.978
BILN.L	-0.964
FEDF.L	-0.96
XFFE.L	-0.96
JPSA.L	-0.959
FLES.L	-0.958
JGSA.L	-0.958
TFRN.L	-0.955
CE9U.L	-0.954
K3C.L	-0.951

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Advanced Oncotherapy PLC 相関 - 通貨/商品

-0.05
( neutral )

-0.04
( neutral )

0.47
( neutral )

-0.08
( neutral )

-0.50
( weak negative )

-0.13
( neutral )

Advanced Oncotherapy PLC 財務諸表

Annual	2022
収益:	£0
総利益:	£0 (0.00 %)
EPS:	£0

FY	2022
収益:	£0
総利益:	£0 (0.00 %)
EPS:	£0

FY	2021
収益:	£0.00
総利益:	£0.00 (0.00 %)
EPS:	£-0.102

FY	2020
収益:	£0.00
総利益:	£0.00 (0.00 %)
EPS:	£-0.0875

Financial Reports:

No articles found.

Advanced Oncotherapy PLC

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.